Intra-tumor heterogeneity from a cancer stem cell perspective.
about
Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysisDickkopf-1 induces angiogenesis via VEGF receptor 2 regulation independent of the Wnt signaling pathway.A versatile pretargeting approach for tumour-selective delivery and activation of TNF superfamily members.Cellular atypia is negatively correlated with immunohistochemical reactivity of CD31 and vWF expression levels in canine hemangiosarcoma.Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients.Cancer stem cells as targets for immunotherapy.Association of epithelial-to-mesenchymal transition circulating tumor cells in non-small cell lung cancer (NSCLC) molecular subgroups.Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids.Bridging the divide: preclinical research discrepancies between triple-negative breast cancer cell lines and patient tumors.Biomarker discovery for renal cancer stem cells.Micropharmacology: An In Silico Approach for Assessing Drug Efficacy Within a Tumor Tissue.Lung cancer stem cells-origin, characteristics and therapy.Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity.In situ characterization of stem cells-like biomarkers in meningiomas.Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell.A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RXStroma-derived IL-6, G-CSF and Activin-A mediated dedifferentiation of lung carcinoma cells into cancer stem cellsThe Viability of Single Cancer Cells after Exposure to Hydrodynamic Shear Stresses in a Spiral Microchannel: A Canine Cutaneous Mast Cell Tumor ModelCells with stemness features are generated from in vitro transformed human fibroblastsSingle cell network analysis with a mixture of Nested Effects ModelsCellular communication promotes mammosphere growth and collective invasion through microtubule‑like structures and angiogenesisThymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities
P2860
Q41094682-9332F505-1C51-48A8-88F6-C36BCBAA3367Q41708730-D013F819-A677-4851-A4A2-63A236E29028Q42378925-D3ADF4EA-53F1-4EB4-AD77-8382CC28B9ADQ47222694-9CA076F0-9161-4B7E-8098-6B649AAD27CEQ47569610-4A449471-2CCC-4629-B4B5-E10B45199022Q48278683-F577FF3D-9F8C-4AE7-8821-37059E176F05Q49218297-E78085BA-DA46-43A0-A114-3A241BF8EC6CQ49237718-09809C49-BEF9-4AAE-B512-3A8D86E6D131Q49619782-4BEFD793-33D0-466D-8B0D-BA24FFB6DC27Q50049701-F5456ADF-EDA2-464B-A874-7A0E08671083Q50103495-CA7F3EA5-F6D0-4BAF-82BE-ABF07AA099E3Q52571052-21628F43-8C83-4B42-AFE7-BC09ED48329DQ52671067-2ADF4234-4AD8-4EAF-8CC9-E865DAF44B85Q54983777-A0AAD603-A9E4-498B-95B7-0AAA6455E2F3Q55254924-CA94DCE9-0B0B-4E3A-A532-81A21CC5A8FCQ55365203-08DDC88E-9E1C-493E-94B6-F325CEC54928Q57148983-C33A16EC-9A4C-4596-9B66-BE830A7E90F1Q57970402-83883408-7269-429C-9FAF-18CD61263085Q58584551-AD066635-5F48-46C0-B1B9-AA66957D4D04Q58740672-A70A40DD-F0D3-4571-9F09-4956C12BA268Q58757818-17F10D97-BE96-4B0C-9550-4AD1D400E53AQ58777021-E48D7A69-35E7-4154-AD4A-A7B1BDFE6F60Q58802359-58782A56-BF14-4944-B5B1-5BC1EB26C1F9
P2860
Intra-tumor heterogeneity from a cancer stem cell perspective.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Intra-tumor heterogeneity from a cancer stem cell perspective.
@en
Intra-tumor heterogeneity from a cancer stem cell perspective.
@nl
type
label
Intra-tumor heterogeneity from a cancer stem cell perspective.
@en
Intra-tumor heterogeneity from a cancer stem cell perspective.
@nl
prefLabel
Intra-tumor heterogeneity from a cancer stem cell perspective.
@en
Intra-tumor heterogeneity from a cancer stem cell perspective.
@nl
P2860
P1433
P1476
Intra-tumor heterogeneity from a cancer stem cell perspective
@en
P2093
Pramudita R Prasetyanti
P2860
P2888
P356
10.1186/S12943-017-0600-4
P5008
P577
2017-02-16T00:00:00Z
P6179
1083844980